News

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community needs to figure out how to keep patients on the drugs long ... to a ...
Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 ... can prevent weight loss, as can ...
Interestingly, in one large database study, patients on GLP-1 medications even ... “game-changing” drugs might remain out of reach for many. Deciding on a weight loss approach — whether ...
Surveys show at least one in eight US adults have given GLP-1 drugs like ... an NYC surgeon and weight loss specialist, told his TikTok followers he’s treated several patients who developed ...
Research suggests these medicines may help quell nicotine cravings, making it easier to quit ... weight loss drug? Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Drugs in ...
GLP-1 is a natural peptide found in the body in many places, including the gastrointestinal (GI) tract and the brain. Weight loss drugs like ... cardiac function in patients with heart ...
GLP-1 medications ... impact on muscle loss. Studies show up to 30% to 40% of weight lost on GLP-1 medications comes from lean muscle mass. That’s a big deal. These drugs suppress appetite ...
Like many survivors ... there’s probably more to it than just the weight loss.” He’s used GLP-1 drugs in about two dozen lymphedema patients so far, calling the results “very good.” ...
Patients with GLP-1 prescriptions for obesity filled ... must balance cost and health outcomes. While the weight-loss drugs work well for many, it said in a statement, “others have ...